Clinical trials recruiting for Metastatic Malignant Neoplasm in the Lung
7
Recruiting trials
48
US states with sites
6
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Stereotactic Body Radiation Therapy | 2 |
| Cisplatin | 1 |
| Panitumumab-IRDye800 | 1 |
| Radiation Therapy Treatment Planning and Simulation | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 3 |
| California | 2 |
| Illinois | 2 |
| Minnesota | 2 |
| New York | 2 |
| Alabama | 1 |
| Alaska | 1 |
| Arizona | 1 |
| Arkansas | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Delaware | 1 |
Top cities
Houston, Texas 3Chicago, Illinois 2Palo Alto, California 2Rochester, Minnesota 2Akron, Ohio 1Albany, New York 1Albuquerque, New Mexico 1Allentown, Pennsylvania 1Amarillo, Texas 1Anaheim, California 1
Self-screener
Recruiting trials
- Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
- Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
- Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
- Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
- Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
- Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Related conditions
Trials recruiting for Metastatic Malignant Neoplasm in the Lung often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Lung Carcinoma 30Stage IVB Lung Cancer AJCC v8 9Stage IVA Lung Cancer AJCC v8 9Stage IV Lung Cancer AJCC v8 45Stage IIIA Lung Cancer AJCC v8 10Stage II Lung Cancer AJCC v8 11Stage I Lung Cancer AJCC v8 8Osteosarcoma 15Metastatic Malignant Solid Neoplasm 21
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Malignant Neoplasm in the Lung trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.